Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.39 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL307700 | 1.00 | GGT1 (0.56) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL94249 | 1.00 | GGT1 (0.56) | GGT1KDM4EMAPTTHRBALOX15 | |
| Hydrochloric Acid SCHEMBL1574244 | 0.98 | GGT1 (0.55) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL5965362 | 0.88 | CPB2 (0.47) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL4996803 | 0.88 | CPB2 (0.47) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL900178 | 0.86 | KDM4E (0.54) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL900182 | 0.86 | KDM4E (0.54) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL17378062 | 0.86 | KDM4E (0.54) | GGT1KDM4EMAPTTHRBALOX15 | |
| Hydrochloric Acid SCHEMBL16993797 | 0.84 | KDM4E (0.52) | GGT1KDM4EMAPTTHRBALOX15 | |
| Lysine SCHEMBL9118672 | 0.83 | GSR (0.61) | GGT1CPB2FOLH1PTGS1SLC7A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190016766-A1 | Use of improved modulators of complement function as cancer therapeutics | BENJAMIN DANIEL E (US) | 2019-01-17 | — | — | US | claimed |
| US-20180369328-A1 | Modulators of Complement Function | FRITZINGER DAVID C (US) | 2018-12-27 | — | — | US | claimed |
| US-20090203585-A1 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ARRAY BIOPHARMA, INC. | 2009-08-13 | — | — | US | claimed |
| US-7525013-B2 | Soybean selection system based on AEC-resistance | UNITED SOYBEAN BOARD (US) | 2009-04-28 | — | — | US | claimed |
| WO-2007130743-A2 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ARRAY BIOPHARMA, INC. (US) | 2007-11-15 | — | — | WO | claimed |
| US-20060117413-A1 | Soybean selection system based on aec-resistance | UNITED SOYBEAN BOARD (US) | 2006-06-01 | — | — | US | claimed |
| US-20060009468-A1 | Method for treatment of cancer | CROOKS PETER A | 2006-01-12 | — | — | US | claimed |
| WO-2005017108-A2 | SOYBEAN SELECTION SYSTEM BASED ON AEC-RESISTANCE | UNITED SOYBEAN BOARD (US) | 2005-02-24 | — | — | WO | claimed |
| US-5859295-A | Canavanine analogs and their use as chemotherapeutic agents | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1999-01-12 | — | — | US | claimed |
| US-5552440-A | Use of L-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1996-09-03 | — | — | US | claimed |
| EP-0422187-B1 | PRODUCTION OF AMINO ACIDS BY METHYLOTROPHIC BACILLUS | UNIV MINNESOTA (US) | 1995-09-20 | — | — | EP | claimed |
| EP-0336387-B1 | PROCESS FOR PRODUCING L-ARGININE | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1993-08-04 | — | — | EP | claimed |
| US-5034319-A | Culture of corynebacterium in a medium of cysteine | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-07-23 | — | — | US | claimed |
| EP-0422187-A1 | PRODUCTION OF AMINO ACIDS BY METHYLOTROPHIC BACILLUS. | UNIV MINNESOTA (US) | 1991-04-17 | — | — | EP | claimed |
| WO-1990012105-A2 | PRODUCTION OF AMINO ACIDS BY METHYLOTROPHIC BACILLUS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1990-10-18 | — | — | WO | claimed |
| EP-0336387-A2 | Process for producing L-arginine | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1989-10-11 | — | — | EP | claimed |
| US-20250171500-A1 | CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS | CALDER BIOSCIENCES INC (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250092094-A1 | CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS | CALDER BIOSCIENCES INC (US) | 2025-03-20 | — | — | US | disclosed |
| US-4368266-A | MUTANTS OF BREVIBACTERIUM OR CORYNEBACTERIUM REQUIRING ACETIC ACID FOR GROWTH | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-01-11 | — | — | US | disclosed |
| US-4347317-A | BREVIBACTERIUM OR CORYNEBACTERIUM MUTANTS | AJINOMOTO COMPANY, INCORPORATED (JP) | 1982-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203585-A1 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | CAPRIN1, NISCH, RPIA | GGT1 2038/4885KDM4E 2843/4885MAPT 2831/4885 |
| US-20060009468-A1 | Method for treatment of cancer | TOP2A, TOP2B, TOP1 | GGT1 362/4885KDM4E 2110/4885MAPT 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.